SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    A Laroche-Clary, V Chaire, V Le Morvan, A Neuville, F Bertucci, S Salas, R Sanfilippo, P Pourquier, A Italiano, BRCA1 haplotype and clinical benefit of trabectedin in soft-tissue sarcoma patients, British Journal of Cancer, 2015, 112, 4, 688

    CrossRef

  2. 2
    Kiran Jagarlamudi, Sara Westberg, Henrik Rönnberg, Staffan Eriksson, Properties of cellular and serum forms of thymidine kinase 1 (TK1) in dogs with acute lymphocytic leukemia (ALL) and canine mammary tumors (CMTs): implications for TK1 as a proliferation biomarker, BMC Veterinary Research, 2014, 10, 1, 228

    CrossRef

  3. 3
    T. Ignatov, A. Poehlmann, A. Ignatov, A. Schinlauer, S. D. Costa, A. Roessner, T. Kalinski, J. Bischoff, BRCA1 promoter methylation is a marker of better response to anthracycline-based therapy in sporadic TNBC, Breast Cancer Research and Treatment, 2013, 141, 2, 205

    CrossRef

  4. 4
    Jin Won Kim, Hyun Jin Cho, Miso Kim, Kyung-Hun Lee, Min A. Kim, Sae-Won Han, Do-Youn Oh, Hyuk-Joon Lee, Seock-Ah Im, Tae-You Kim, Han-Kwang Yang, Woo Ho Kim, Yung-Jue Bang, Differing effects of adjuvant chemotherapy according to BRCA1 nuclear expression in gastric cancer, Cancer Chemotherapy and Pharmacology, 2013, 71, 6, 1435

    CrossRef

  5. 5
    Richard B Richardson, p53mutations associated with aging-related rise in cancer incidence rates, Cell Cycle, 2013, 12, 15, 2468

    CrossRef

  6. 6
    Wenjiao Chen, Jian Wang, Xiao Li, Jingying Li, Li Zhou, Tianzhu Qiu, Meiling Zhang, Ping Liu, Prognostic significance of BRCA1 expression in gastric cancer, Medical Oncology, 2013, 30, 1

    CrossRef

  7. 7
    Steven A. Narod, Breast cancer in young women, Nature Reviews Clinical Oncology, 2012, 9, 8, 460

    CrossRef

  8. 8
    A. M. M. Oonk, C. van Rijn, M. M. Smits, L. Mulder, N. Laddach, S. P. Savola, J. Wesseling, S. Rodenhuis, A. L. T. Imholz, E. H. Lips, Clinical correlates of 'BRCAness' in triple-negative breast cancer of patients receiving adjuvant chemotherapy, Annals of Oncology, 2012, 23, 9, 2301

    CrossRef

  9. 9
    Jin Xu, Baosheng Wang, Yanjun Zhang, Ruihui Li, Yuehua Wang, Shaokun Zhang, Clinical implications for BRCA gene mutation in breast cancer, Molecular Biology Reports, 2012, 39, 3, 3097

    CrossRef

  10. 10
    Y. H. Park, S. J. Lee, E. Y. Cho, Y. L. Choi, J. E. Lee, S. J. Nam, J.- H. Yang, J. H. Shin, E. Y. Ko, B.- K. Han, J. S. Ahn, Y.- H. Im, Clinical relevance of TNM staging system according to breast cancer subtypes, Annals of Oncology, 2011, 22, 7, 1554

    CrossRef

  11. 11
    Guo-Fang Ding, Yin-Feng Xu, Zui-Su Yang, Yi-Lin Ding, Hai-Fei Fang, Hong-Ping Zhao, Coexpression of the mutated BRCA1 mRNA and p53 mRNA and its association in Chinese prostate cancer, Urologic Oncology: Seminars and Original Investigations, 2011, 29, 2, 145

    CrossRef

  12. 12
    Antoine Italiano, Armelle Laurand, Audrey Laroche, Paolo Casali, Roberta Sanfilippo, Axel Le Cesne, Ian Judson, Jean-Yves Blay, Isabelle Ray-Coquard, Binh Bui, Jean-Michel Coindre, Antonio Nieto, Juan-Carlos Tercero, Jose Jimeno, Jacques Robert, Philippe Pourquier, ERCC5/XPG, ERCC1, and BRCA1 gene status and clinical benefit of trabectedin in patients with soft tissue sarcoma, Cancer, 2011, 117, 15
  13. 13
    Pawel Domagala, Tomasz Huzarski, Jan Lubinski, Karol Gugala, Wenancjusz Domagala, Immunophenotypic predictive profiling of BRCA1-associated breast cancer, Virchows Archiv, 2011, 458, 1, 55

    CrossRef

  14. 14
    Angelo Di Leo, Erica Moretti, Catherine Oakman, Laura Biganzoli, Libero Santarpia, Predictive molecular markers of anthracycline effectiveness in early breast cancer, European Journal of Cancer Supplements, 2011, 9, 2, 16

    CrossRef

  15. 15
    Sarah Barton, Nicholas C. Turner, Handbook of Metastatic Breast Cancer, 2011,

    CrossRef

  16. You have full text access to this Open Access content16
    Hyun Jeong Shim, Joo Young Yun, Jun Eul Hwang, Woo Kyun Bae, Sang Hee Cho, Ji Hee Lee, Hee Nam Kim, Min Ho Shin, Sun Seog Kweon, Jae Hyuk Lee, Hyeoung Joon Kim, Ik Joo Chung, BRCA1 and XRCC1 polymorphisms associated with survival in advanced gastric cancer treated with taxane and cisplatin, Cancer Science, 2010, 101, 5
  17. 17
    Eun-Ha Lee, Sue K. Park, Boyoung Park, Sung-Won Kim, Min Hyuk Lee, Sei Hyun Ahn, Byung Ho Son, Keun-Young Yoo, Daehee Kang, Effect of BRCA1/2 mutation on short-term and long-term breast cancer survival: a systematic review and meta-analysis, Breast Cancer Research and Treatment, 2010, 122, 1, 11

    CrossRef

  18. 18
    Melissa Price, Alvaro N.A. Monteiro, Fine tuning chemotherapy to match BRCA1 status, Biochemical Pharmacology, 2010, 80, 5, 647

    CrossRef

  19. 19
    Yasuo Miyoshi, Masafumi Kurosumi, Junichi Kurebayashi, Nariaki Matsuura, Masato Takahashi, Eriko Tokunaga, Chiyomi Egawa, Norikazu Masuda, Seishi Kono, Koji Morimoto, Seung Jin Kim, Masatsugu Okishiro, Tetsu Yanagisawa, Satsuki Ueda, Tetsuya Taguchi, Yasuhiro Tamaki, Shinzaburo Noguchi, Predictive factors for anthracycline-based chemotherapy for human breast cancer, Breast Cancer, 2010, 17, 2, 103

    CrossRef

  20. 20
    A F Munro, D A Cameron, J M S Bartlett, Targeting anthracyclines in early breast cancer: new candidate predictive biomarkers emerge, Oncogene, 2010, 29, 38, 5231

    CrossRef

  21. 21
    Alison H. Trainer, Craig R. Lewis, Kathy Tucker, Bettina Meiser, Michael Friedlander, Robyn L. Ward, The role of BRCA mutation testing in determining breast cancer therapy, Nature Reviews Clinical Oncology, 2010, 7, 12, 708

    CrossRef

  22. 22
    Marina Pajic, Ariena Kersbergen, Frank van Diepen, Anita Pfauth, Jos Jonkers, Piet Borst, Sven Rottenberg, Tumor-initiating cells are not enriched in cisplatin-surviving BRCA1;p53-deficient mammary tumor cells in vivo, Cell Cycle, 2010, 9, 18, 3804

    CrossRef

  23. 23
    Xinran Xu, Marilie D. Gammon, Yujing Zhang, Timothy H. Bestor, Steven H. Zeisel, James G. Wetmur, Sylvan Wallenstein, Patrick T. Bradshaw, Gail Garbowski, Susan L. Teitelbaum, Alfred I. Neugut, Regina M. Santella, Jia Chen, BRCA1 promoter methylation is associated with increased mortality among women with breast cancer, Breast Cancer Research and Treatment, 2009, 115, 2, 397

    CrossRef

  24. 24
    G. Metro, Z. Zheng, A. Fabi, M. Schell, B. Antoniani, M. Mottolese, A. N. Monteiro, P. Vici, S. Lara Rivera, D. Boulware, F. Cognetti, G. Bepler, In SituProtein Expression of RRM1, ERCC1, and BRCA1 in Metastatic Breast Cancer Patients Treated with Gemcitabine-Based Chemotherapy, Cancer Investigation, 2009, 28, 2, 172

    CrossRef

  25. 25
    Sung-Won Kim, Korean Hereditary Breast Cancer, Journal of the Korean Medical Association, 2009, 52, 10, 952

    CrossRef

  26. 26
    C. Courtillot, P. Touraine, Attitude pratique devant une famille à haut risque de cancer du sein et/ou de l’ovaire : le point de vue de l’endocrinologue, Annales d'Endocrinologie, 2008, 69, 3, 193

    CrossRef

  27. 27
    Yasuo Miyoshi, Keiko Murase, Koushi Oh, Basal-like subtype and BRCA1 dysfunction in breast cancers, International Journal of Clinical Oncology, 2008, 13, 5, 395

    CrossRef

  28. 28
    Heunglae Cho, Cheoljin Kim, Sungkwang Park, Minkyung Oh, Jinyong Lee, Kijung Ahn, Clinical Outcome after Breast Conserving Surgery and Radiation Therapy for Early Breast Cancer, The Journal of the Korean Society for Therapeutic Radiology and Oncology, 2008, 26, 4, 204

    CrossRef

  29. 29
    S. Taneja, A.J. Evans, E.A. Rakha, A.R. Green, G. Ball, I.O. Ellis, The mammographic correlations of a new immunohistochemical classification of invasive breast cancer, Clinical Radiology, 2008, 63, 11, 1228

    CrossRef

  30. 30
    Lucy Gossage, Srinivasan Madhusudan, Cancer Pharmacogenomics, Molecular Diagnosis & Therapy, 2007, 11, 6, 361

    CrossRef

  31. 31
    Gad Rennert, Shantih Bisland-Naggan, Ofra Barnett-Griness, Naomi Bar-Joseph, Shiyu Zhang, Hedy S. Rennert, Steven A. Narod, Clinical Outcomes of Breast Cancer in Carriers ofBRCA1andBRCA2Mutations, New England Journal of Medicine, 2007, 357, 2, 115

    CrossRef

  32. 32
    Fabienne Patricia Liebens, Birgit Carly, Ann Pastijn, Serge Rozenberg, Management of BRCA1/2 associated breast cancer: A systematic qualitative review of the state of knowledge in 2006, European Journal of Cancer, 2007, 43, 2, 238

    CrossRef

  33. 33
    Leslie K. Diaz, Vincent L. Cryns, W. Fraser Symmans, Nour Sneige, Triple Negative Breast Carcinoma and the Basal Phenotype: From Expression Profiling to Clinical Practice, Advances in Anatomic Pathology, 2007, 14, 6, 419

    CrossRef

  34. 34
    Angelo Di Leo, Wederson M. Claudino, Marta Pestrin, Sara Licitra, Laura Biganzoli, Using specific cytotoxics with a targeted mind, The Breast, 2007, 16, 120

    CrossRef

  35. 35
    Mark Robson, Hereditary Breast Cancer, 2007,

    CrossRef

  36. 36
    RL Bowen, J Stebbing, LJ Jones, A review of the ethnic differences in breast cancer, Pharmacogenomics, 2006, 7, 6, 935

    CrossRef

  37. 37
    Paul B. Mullan, Julia J. Gorski, D. Paul Harkin, BRCA1—A good predictive marker of drug sensitivity in breast cancer treatment?, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2006, 1766, 2, 205

    CrossRef

  38. 38
    Fruma Yehiely, Jose V. Moyano, Joseph R. Evans, Torsten O. Nielsen, Vincent L. Cryns, Deconstructing the molecular portrait of basal-like breast cancer, Trends in Molecular Medicine, 2006, 12, 11, 537

    CrossRef

  39. 39
    Michael P. Lux, Peter A. Fasching, Matthias W. Beckmann, Hereditary breast and ovarian cancer: review and future perspectives, Journal of Molecular Medicine, 2006, 84, 1, 16

    CrossRef

  40. 40
    H M Verkooijen, P O Chappuis, E Rapiti, G Vlastos, G Fioretta, S Sarp, A P Sappino, H Schubert, C Bouchardy, Impact of familial risk factors on management and survival of early-onset breast cancer: a population-based study, British Journal of Cancer, 2006, 94, 2, 231

    CrossRef

  41. 41
    E Honrado, A Osorio, J Palacios, J Benitez, Pathology and gene expression of hereditary breast tumors associated with BRCA1, BRCA2 and CHEK2 gene mutations, Oncogene, 2006, 25, 43, 5837

    CrossRef

  42. 42
    Dalia M. Abd El-Rehim, Graham Ball, Sarah E. Pinder, Emad Rakha, Claire Paish, John F.R. Robertson, Douglas Macmillan, Roger W. Blamey, Ian O. Ellis, High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses, International Journal of Cancer, 2005, 116, 3
  43. 43
    A Kataki, IP Gomatos, N Pararas, A Armakolas, D Panousopoulos, G Karantzikos, D Voros, G Zografos, C Markopoulos, E Leandros, MM Konstadoulakis, Identification of germline BRCA1 and BRCA2 genetic alterations in Greek breast cancer moderate-risk and low-risk individuals – correlation with clinicopathological data, Clinical Genetics, 2005, 67, 4
  44. 44
    Emiliano Honrado, Javier Benítez, José Palacios, The molecular pathology of hereditary breast cancer: genetic testing and therapeutic implications, Modern Pathology, 2005, 18, 10, 1305

    CrossRef

  45. 45
    Danila Coradini, Maria Grazia Daidone, Biomolecular prognostic factors in breast cancer, Current Opinion in Obstetrics and Gynecology, 2004, 16, 1, 49

    CrossRef

  46. 46
    Steven A. Narod, William D. Foulkes, BRCA1 and BRCA2: 1994 and beyond, Nature Reviews Cancer, 2004, 4, 9, 665

    CrossRef

  47. 47
    Shirley V. Hodgson, Patrick J. Morrison, Melita Irving, Breast cancer genetics: Unsolved questions and open perspectives in an expanding clinical practice, American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2004, 129C, 1
  48. 48
    Suxing Liu, W. Robert Bishop, Bimal Dasmahapatra, Yaolin Wang, Pharmacogenomics of the p53 tumor suppressor and its role in cancer chemoresistance, Drug Development Research, 2004, 62, 3
  49. 49
    C. Blake Gilks, Subclassification of Ovarian Surface Epithelial Tumors Based on Correlation of Histologic and Molecular Pathologic Data, International Journal of Gynecological Pathology, 2004, 23, 3, 200

    CrossRef

  50. 50
    Mahmoud El-Tamer, Donna Russo, Andrea Troxel, Lourdes P. Bernardino, Robert Mazziotta, Alison Estabrook, Beth-Ann Ditkoff, Freya Schnabel, Mahesh Mansukhani, Survival and Recurrence After Breast Cancer in BRCA1/2 Mutation Carriers, Annals of Surgical Oncology, 2004, 11, 2, 157

    CrossRef

  51. 51
    R. D. Kennedy, J. E. Quinn, P. B. Mullan, P. G. Johnston, D. P. Harkin, The Role of BRCA1 in the Cellular Response to Chemotherapy, JNCI Journal of the National Cancer Institute, 2004, 96, 22, 1659

    CrossRef

  52. 52
    William D. Foulkes, Kelly Metcalfe, Wedad Hanna, Henry T. Lynch, Parviz Ghadirian, Nadine Tung, Olofunmilayo Olopade, Barbara Weber, Jane McLennan, Ivo A. Olivotto, Ping Sun, Pierre O. Chappuis, Louis R. Bégin, Jean-Sébastien Brunet, Steven A. Narod, Disruption of the expected positive correlation between breast tumor size and lymph node status in BRCA1-related breast carcinoma, Cancer, 2003, 98, 8
  53. 53
    M. A. Rookus, R. Brohet, F. E. van Leeuwen, Re: Oral Contraceptives and the Risk of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers, JNCI Journal of the National Cancer Institute, 2003, 95, 13, 1012

    CrossRef